학술논문

Influence of FCGR3A-V158F polymorphism on the therapeutic response to Ocrelizumab in patients with Multiple Sclerosis
Document Type
Journal
Source
EUROPEAN JOURNAL OF NEUROLOGY; JUN 2023, 30 p378-p378, 1p. Supplement: 1
Subject
Language
English
ISSN
14681331